SYNOPSIS: Mukul Agrawal ups stake in Tatva Chintan Pharma Chem, a ₹3,239 crore specialty chemicals leader with 62% exports, strong Q2FY26 recovery, and dominance in PTCs, SDAs, and Glymes.

Ace investor Mukul Agrawal has increased his stake in a lesser-known but strong company that quietly leads its segment. Even though it doesn’t grab headlines, the business has solid growth, stable performance, and a strong market position. His move has created fresh interest in the stock, check the below article to know more.

Tatva Chintan Pharma Chem Ltd , with a market capitalization of Rs. 3,239 crore, is trading at Rs. 1,385 per equity share, down by 0.16 percent from its previous day’s close price of Rs. 1,387.20 per equity share.

About the Company

Established in 1996 by first-generation engin

See Full Page